NEW YORK AP Drug maker Bristol-Myers Squibb Co. said Tuesday it was cooperating with a Federal Trade Commission request to turn over documents related to last year’s failed Plavix patent settlement.

The company said in a filing with the Securities and Exchange Commission that the FTC requested the documents on March 21 through a civil investigative demand.